Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (201-210 of 329) with videos related to

Pageof 33
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.
Infectious Agents and Cancer|February 7, 2021
No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigationRaphaël Borie, Valérie Caro, Hilario Nunes, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Cancers|October 23, 2021
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and ChemotherapySamy Chelabi, Xavier Mignard, Karen Leroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancerOlivier Calvayrac, Anne Pradines, Isabelle Raymond-Letron, et al.
Respiratory Medicine and Research|December 23, 2023
U-net convolutional neural network applied to progressive fibrotic interstitial lung disease: Is progression at CT scan associated with a clinical outcome?Xavier Guerra, Simon Rennotte, Catalin Fetita, et al.
Scandinavian Journal of Immunology|December 8, 2021
Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structuresMarie-Caroline Dieu-Nosjean, Martine Antoine, Claire Danel, et al.
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
Pageof 33

Showing results (201-210 of 329) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.
Infectious Agents and Cancer|February 7, 2021
No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigationRaphaël Borie, Valérie Caro, Hilario Nunes, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Cancers|October 23, 2021
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and ChemotherapySamy Chelabi, Xavier Mignard, Karen Leroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancerOlivier Calvayrac, Anne Pradines, Isabelle Raymond-Letron, et al.
Respiratory Medicine and Research|December 23, 2023
U-net convolutional neural network applied to progressive fibrotic interstitial lung disease: Is progression at CT scan associated with a clinical outcome?Xavier Guerra, Simon Rennotte, Catalin Fetita, et al.
Scandinavian Journal of Immunology|December 8, 2021
Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structuresMarie-Caroline Dieu-Nosjean, Martine Antoine, Claire Danel, et al.
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
Pageof 33